Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TALIGLUCERASE ALFA for Lipidosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where TALIGLUCERASE ALFA was used for Lipidosis.

Most Reported Side Effects for TALIGLUCERASE ALFA

Side Effect Reports % Deaths Hosp.
Fatigue 59 13.0% 4 11
Arthralgia 43 9.5% 1 9
Off label use 43 9.5% 2 6
Pyrexia 40 8.8% 6 12
Malaise 39 8.6% 6 12
Pain 38 8.4% 4 13
Inappropriate schedule of product administration 37 8.2% 2 14
Pain in extremity 37 8.2% 2 11
Headache 36 8.0% 1 3
Nausea 33 7.3% 1 5
Dyspnoea 32 7.1% 2 7
Back pain 30 6.6% 1 7
Covid-19 27 6.0% 2 7
Fall 27 6.0% 7 16
Cough 26 5.7% 1 8

Other Indications for TALIGLUCERASE ALFA

Gaucher's disease (275) Gaucher's disease type i (49) Gaucher's disease type iii (14)

Other Drugs Used for Lipidosis

AGALSIDASE BETA (289) IMIGLUCERASE (103) MIGLUSTAT (60) CHENODIOL (57) ELIGLUSTAT (40) VELAGLUCERASE ALFA (31) MIGALASTAT (13) SEBELIPASE ALFA (11) CHOLIC ACID (9)

Related Pages

TALIGLUCERASE ALFA Full Profile All Lipidosis Drugs TALIGLUCERASE ALFA Demographics TALIGLUCERASE ALFA Timeline